We are live on
!
Find out more
ONC
BeOne Medicines Ltd
39 hedge funds and large institutions have $313M invested in BeOne Medicines Ltd in 2016 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
31% more capital invested
Capital invested by funds: $239M → $313M (+$73.7M)
0% more funds holding
Funds holding: 39 → 39 (0)
0% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 9
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
39
Holders Change
–
Holders Change %
0%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
9
Increased
7
Reduced
8
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.6M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$18.8M |
| 3 |
Brown Advisory
Baltimore,
Maryland
|
+$6.93M |
| 4 |
PA
Perceptive Advisors
New York
|
+$3.83M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$2.04M |
Top Sellers
| 1 |
TD Asset Management
Toronto,
Ontario, Canada
|
-$5.16M |
| 2 |
ICP
Indus Capital Partners
New York
|
-$3.12M |
| 3 |
Millennium Management
New York
|
-$616K |
| 4 |
O
OrbiMed
New York
|
-$385K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$346K |
